We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Artificial Light Stimulates Cancer Growth

By Biotechdaily staff writers
Posted on 29 Dec 2005
A study of laboratory mice has shown that exposure to artificial light at night stimulated the growth of human breast tumors by suppressing the levels of melatonin.

In contrast, extended periods of darkness at night greatly slowed the growth of the tumors. More...
These results help explain why women who work night shifts have a higher rate of breast cancer than other women. In advanced industrial countries such as the United States, it provides a new explanation for the epidemic rise in breast cancer incidence. The study findings were reported in the December 1, 2005, issue of Cancer Research.

"We know that many tumors are largely dependent on a nutrient called linoleic acid, an essential fatty acid, in order to grow,” observed lead author David Blask, M.D., Ph.D., a neuroendocrinologist with the Bassett Research Institute (Cooperstown, NY, USA). "Melatonin interferes with the tumor's ability to use linoleic acid as a growth signal, which causes tumor metabolism and growth activity to shut down.

To test this hypothesis, the researchers injected human breast cancer cells into laboratory mice. After these cells developed into cancerous tumors, the tumors were implanted into female rats where they could continue to grow. The researchers took blood samples from 12 healthy volunteers under three different conditions: during the daytime, during the night following two hours of complete darkness, and during the night following 90 minutes of exposure to bright fluorescent light. These blood samples were then pumped directly through the developing tumors.

"The melatonin-rich blood collected from subjects while in total darkness severely slowed the growth of tumors,” said Dr. Blask. "These results are due to a direct effect of the melatonin on the cancer cells. The melatonin is clearly suppressing tumor development and growth.”

In contrast, tests with the melatonin-depleted blood from light-exposed subjects stimulated tumor growth. "We observed rapid growth comparable to that seen with administration of daytime blood samples, when tumor activity is particularly high,” Dr. Blask explained.

Melatonin exerts a strong influence on the body's circadian rhythm, according to the researchers. The disruption of the circadian clock is associated with cancer in humans, and interference with that internal timekeeping can effect a change in favor of tumor development. These results may lead to more artificial lighting and perhaps the use of lighting that has a wavelength and intensity that do not disrupt melatonin levels and internal timekeeping.

"Day workers who spend their time indoors would benefit from lighting that better mimics sunlight,” added Dr. Blask. "Companies that employ shift workers could introduce lighting that allows the workers to see without disrupting their circadian and melatonin rhythms.”




Related Links:
Bassett Hospital

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Immunofluorescence Analyzer
IFA System
New
Drug Testing Assays
Atellica DT 250 Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Microbiology

view channel
Image: Schematic overview of the CRISPR-Assisted Nanodroplet-pairing Platform for Differential Identification of NTM (CANDI). The platform combines broad-range amplification using conserved regions of the 16S and 23S rRNA genes with species-specific CRISPR recognition. Fluorescence-coded CRISPR droplets are paired with sample droplets containing amplified products, enabling multiplexed target recognition and signal decoding (Image Credit: Yiwen Yang, Jingsong Xu, Dakang Xu)

Nanodroplet CRISPR Technology Supports Rapid, Multiplexed Mycobacterial Identification

Mycobacterial infections are difficult to diagnose because closely related species can have different clinical and therapeutic implications. Nontuberculous mycobacteria (NTM) are increasingly recognized... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: TruVerus is designed to deliver a broad menu of routine blood tests from a small blood sample on a single, automated benchtop platform (Photo courtesy of Truvian Health)

Collaboration Advances Automated Benchtop Platform for Routine Blood Testing

Routine blood testing is central to clinical decision-making, but access can vary across laboratory and healthcare settings. Broader use of automated benchtop platforms may help integrate testing more... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.